Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
OXB in Bedford, MA is seeking a Senior Scientist for Analytical Development Operations to lead method development, transfers, and QC support for viral vector programs. You will guide GMP analytics, supervise cross-functional teams, and drive successful tech transfers and method validations.
The role emphasizes client-facing collaboration, data trending, and mentoring junior staff within a world-class analytical development environment.
AtOXB, our people are at the heart of everything we do.We’reon a mission to enable life-changing therapies to reach patients around the world—andwe’relooking for passionate individuals who embody our core values every day:Responsible, Responsive, Resilient, and Respectful.
We are currently recruiting for a Senior Scientist, Analytical Development Operations to join the Analytical Development team in our Bedford, MA location. Reporting to the Vice President of Development Services, the purpose of the role is providing scientific and operational leadership for analytical method development operations and systems, qualification, transfer, and lifecycle management supporting viral vector process development and GMP manufacturing programs, playing a key part in advancing our mission and making a real difference.
This role does not offer sponsorship for work authorization. External applicants must be eligible to work in the United States.
OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.
We want you to feel inspired every day. At OXB,we’future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.
Nearest Major Market: New Bedford